These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
480 related articles for article (PubMed ID: 29037245)
1. Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain. Asahchop EL; Meziane O; Mamik MK; Chan WF; Branton WG; Resch L; Gill MJ; Haddad E; Guimond JV; Wainberg MA; Baker GB; Cohen EA; Power C Retrovirology; 2017 Oct; 14(1):47. PubMed ID: 29037245 [TBL] [Abstract][Full Text] [Related]
2. Lentiviral Infections Persist in Brain despite Effective Antiretroviral Therapy and Neuroimmune Activation. Mohammadzadeh N; Roda W; Branton WG; Clain J; Rabezanahary H; Zghidi-Abouzid O; Gelman BB; Angel JB; Cohen EA; Gill MJ; Li M; Estaquier J; Power C mBio; 2021 Dec; 12(6):e0278421. PubMed ID: 34903055 [TBL] [Abstract][Full Text] [Related]
3. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection. Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407 [TBL] [Abstract][Full Text] [Related]
4. HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy. Honeycutt JB; Thayer WO; Baker CE; Ribeiro RM; Lada SM; Cao Y; Cleary RA; Hudgens MG; Richman DD; Garcia JV Nat Med; 2017 May; 23(5):638-643. PubMed ID: 28414330 [TBL] [Abstract][Full Text] [Related]
5. An Elvitegravir Nanoformulation Crosses the Blood-Brain Barrier and Suppresses HIV-1 Replication in Microglia. Gong Y; Zhi K; Nagesh PKB; Sinha N; Chowdhury P; Chen H; Gorantla S; Yallapu MM; Kumar S Viruses; 2020 May; 12(5):. PubMed ID: 32443728 [TBL] [Abstract][Full Text] [Related]
6. HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy. Satheesan S; Li H; Burnett JC; Takahashi M; Li S; Wu SX; Synold TW; Rossi JJ; Zhou J J Virol; 2018 Apr; 92(7):. PubMed ID: 29343582 [TBL] [Abstract][Full Text] [Related]
8. Small molecule ONC201 inhibits HIV-1 replication in macrophages via FOXO3a and TRAIL. Zhao R; Li Y; Gorantla S; Poluektova LY; Lin H; Gao F; Wang H; Zhao J; Zheng JC; Huang Y Antiviral Res; 2019 Aug; 168():134-145. PubMed ID: 31158413 [TBL] [Abstract][Full Text] [Related]
9. Macrophages but not Astrocytes Harbor HIV DNA in the Brains of HIV-1-Infected Aviremic Individuals on Suppressive Antiretroviral Therapy. Ko A; Kang G; Hattler JB; Galadima HI; Zhang J; Li Q; Kim WK J Neuroimmune Pharmacol; 2019 Mar; 14(1):110-119. PubMed ID: 30194646 [TBL] [Abstract][Full Text] [Related]
10. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. Furtado MR; Callaway DS; Phair JP; Kunstman KJ; Stanton JL; Macken CA; Perelson AS; Wolinsky SM N Engl J Med; 1999 May; 340(21):1614-22. PubMed ID: 10341273 [TBL] [Abstract][Full Text] [Related]
11. A mature macrophage is a principal HIV-1 cellular reservoir in humanized mice after treatment with long acting antiretroviral therapy. Araínga M; Edagwa B; Mosley RL; Poluektova LY; Gorantla S; Gendelman HE Retrovirology; 2017 Mar; 14(1):17. PubMed ID: 28279181 [TBL] [Abstract][Full Text] [Related]
12. HIV-1 infection of microglial cells in a reconstituted humanized mouse model and identification of compounds that selectively reverse HIV latency. Llewellyn GN; Alvarez-Carbonell D; Chateau M; Karn J; Cannon PM J Neurovirol; 2018 Apr; 24(2):192-203. PubMed ID: 29256041 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic Suppression of HIV in Myeloid Cells by the BRD4-Selective Small Molecule Modulator ZL0580. Alamer E; Zhong C; Liu Z; Niu Q; Long F; Guo L; Gelman BB; Soong L; Zhou J; Hu H J Virol; 2020 May; 94(11):. PubMed ID: 32188727 [TBL] [Abstract][Full Text] [Related]
14. Early Initiation of Antiretroviral Therapy Can Functionally Control Productive HIV-1 Infection in Humanized-BLT Mice. Li Q; Tso FY; Kang G; Lu W; Li Y; Fan W; Yuan Z; Destache CJ; Wood C J Acquir Immune Defic Syndr; 2015 Aug; 69(5):519-27. PubMed ID: 26167617 [TBL] [Abstract][Full Text] [Related]
15. A Quantitative Approach to SIV Functional Latency in Brain Macrophages. Abreu C; Shirk EN; Queen SE; Mankowski JL; Gama L; Clements JE J Neuroimmune Pharmacol; 2019 Mar; 14(1):23-32. PubMed ID: 30167896 [TBL] [Abstract][Full Text] [Related]
16. ART influences HIV persistence in the female reproductive tract and cervicovaginal secretions. Olesen R; Swanson MD; Kovarova M; Nochi T; Chateau M; Honeycutt JB; Long JM; Denton PW; Hudgens MG; Richardson A; Tolstrup M; Østergaard L; Wahl A; Garcia JV J Clin Invest; 2016 Mar; 126(3):892-904. PubMed ID: 26854925 [TBL] [Abstract][Full Text] [Related]
17. HIV latency in the humanized BLT mouse. Marsden MD; Kovochich M; Suree N; Shimizu S; Mehta R; Cortado R; Bristol G; An DS; Zack JA J Virol; 2012 Jan; 86(1):339-47. PubMed ID: 22072769 [TBL] [Abstract][Full Text] [Related]
18. Human Interleukin-34 facilitates microglia-like cell differentiation and persistent HIV-1 infection in humanized mice. Mathews S; Branch Woods A; Katano I; Makarov E; Thomas MB; Gendelman HE; Poluektova LY; Ito M; Gorantla S Mol Neurodegener; 2019 Mar; 14(1):12. PubMed ID: 30832693 [TBL] [Abstract][Full Text] [Related]
19. Chemokine CXCL8 promotes HIV-1 replication in human monocyte-derived macrophages and primary microglia via nuclear factor-κB pathway. Mamik MK; Ghorpade A PLoS One; 2014; 9(3):e92145. PubMed ID: 24662979 [TBL] [Abstract][Full Text] [Related]
20. Raltegravir blocks the infectivity of red-fluorescent-protein (mCherry)-labeled HIV-1 Ogata-Aoki H; Higashi-Kuwata N; Hattori SI; Hayashi H; Danish M; Aoki M; Shiotsu C; Hashiguchi Y; Hamada A; Kobayashi H; Ihn H; Okada S; Mitsuya H Antiviral Res; 2018 Jan; 149():78-88. PubMed ID: 28893602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]